225 related articles for article (PubMed ID: 36209926)
1. Anti-inflammatory effects of ellagic acid and vanillic acid against quinolinic acid-induced rat model of Huntington's disease by targeting IKK-NF-κB pathway.
Bains M; Kaur J; Akhtar A; Kuhad A; Sah SP
Eur J Pharmacol; 2022 Nov; 934():175316. PubMed ID: 36209926
[TBL] [Abstract][Full Text] [Related]
2. Sertraline and venlafaxine improves motor performance and neurobehavioral deficit in quinolinic acid induced Huntington's like symptoms in rats: Possible neurotransmitters modulation.
Gill JS; Jamwal S; Kumar P; Deshmukh R
Pharmacol Rep; 2017 Apr; 69(2):306-313. PubMed ID: 28178592
[TBL] [Abstract][Full Text] [Related]
3. Minocycline modulates neuroprotective effect of hesperidin against quinolinic acid induced Huntington's disease like symptoms in rats: behavioral, biochemical, cellular and histological evidences.
Kumar A; Chaudhary T; Mishra J
Eur J Pharmacol; 2013 Nov; 720(1-3):16-28. PubMed ID: 24211676
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of roflumilast against quinolinic acid-induced rat model of Huntington's disease through inhibition of NF-κB mediated neuroinflammatory markers and activation of cAMP/CREB/BDNF signaling pathway.
Saroj P; Bansal Y; Singh R; Akhtar A; Sodhi RK; Bishnoi M; Sah SP; Kuhad A
Inflammopharmacology; 2021 Apr; 29(2):499-511. PubMed ID: 33517508
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effect of naringin, a flavone glycoside in quinolinic acid-induced neurotoxicity: Possible role of PPAR-γ, Bax/Bcl-2, and caspase-3.
Cui J; Wang G; Kandhare AD; Mukherjee-Kandhare AA; Bodhankar SL
Food Chem Toxicol; 2018 Nov; 121():95-108. PubMed ID: 30130594
[TBL] [Abstract][Full Text] [Related]
6. NMDA and non-NMDA receptor-stimulated IkappaB-alpha degradation: differential effects of the caspase-3 inhibitor DEVD.CHO, ethanol and free radical scavenger OPC-14117.
Nakai M; Qin Z; Wang Y; Chase TN
Brain Res; 2000 Mar; 859(2):207-16. PubMed ID: 10719066
[TBL] [Abstract][Full Text] [Related]
7. Suppressing inflammatory cascade by cyclo-oxygenase inhibitors attenuates quinolinic acid induced Huntington's disease-like alterations in rats.
Kalonia H; Kumar A
Life Sci; 2011 Apr; 88(17-18):784-91. PubMed ID: 21362433
[TBL] [Abstract][Full Text] [Related]
8. Role of LOX/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: protective effect of licofelone.
Kumar P; Kalonia H; Kumar A
Br J Pharmacol; 2011 Sep; 164(2b):644-54. PubMed ID: 21486276
[TBL] [Abstract][Full Text] [Related]
9. Improvement of mitochondrial NAD(+)/FAD(+)-linked state-3 respiration by caffeine attenuates quinolinic acid induced motor impairment in rats: implications in Huntington's disease.
Mishra J; Kumar A
Pharmacol Rep; 2014 Dec; 66(6):1148-55. PubMed ID: 25443748
[TBL] [Abstract][Full Text] [Related]
10. Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-kappaB, iNOS, COX-2, TNF-alpha, and IL-6 in 1,2-dimethylhydrazine-induced rat colon carcinogenesis.
Umesalma S; Sudhandiran G
Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):650-5. PubMed ID: 20406206
[TBL] [Abstract][Full Text] [Related]
11. Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.
Colle D; Hartwig JM; Soares FA; Farina M
Brain Res Bull; 2012 Mar; 87(4-5):397-405. PubMed ID: 22245028
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of montelukast against quinolinic acid/malonic acid induced neurotoxicity: possible behavioral, biochemical, mitochondrial and tumor necrosis factor-α level alterations in rats.
Kalonia H; Kumar P; Kumar A; Nehru B
Neuroscience; 2010 Nov; 171(1):284-99. PubMed ID: 20813166
[TBL] [Abstract][Full Text] [Related]
13. Bilateral quinolinic acid-induced lipid peroxidation, decreased striatal monoamine levels and neurobehavioral deficits are ameliorated by GIP receptor agonist D-Ala
Verma MK; Goel R; Nandakumar K; Nemmani KVS
Eur J Pharmacol; 2018 Jun; 828():31-41. PubMed ID: 29577894
[TBL] [Abstract][Full Text] [Related]
14. Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease.
Ryu JK; Kim SU; McLarnon JG
Exp Neurol; 2004 May; 187(1):150-9. PubMed ID: 15081596
[TBL] [Abstract][Full Text] [Related]
15. Protective Effect of Spermidine Against Excitotoxic Neuronal Death Induced by Quinolinic Acid in Rats: Possible Neurotransmitters and Neuroinflammatory Mechanism.
Jamwal S; Singh S; Kaur N; Kumar P
Neurotox Res; 2015 Aug; 28(2):171-84. PubMed ID: 26078029
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin L plays a role in quinolinic acid-induced NF-Κb activation and excitotoxicity in rat striatal neurons.
Wang YR; Qin S; Han R; Wu JC; Liang ZQ; Qin ZH; Wang Y
PLoS One; 2013; 8(9):e75702. PubMed ID: 24073275
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone synergizes the neuroprotective effects of valproic acid against quinolinic acid-induced neurotoxicity in rats: targeting PPARγ and HDAC pathways.
Mishra J; Chaudhary T; Kumar A
Neurotox Res; 2014 Aug; 26(2):130-51. PubMed ID: 24566814
[TBL] [Abstract][Full Text] [Related]
18. Ellagic acid prevents 3-nitropropionic acid induced symptoms of Huntington's disease.
Sharma P; Kumar M; Bansal N
Naunyn Schmiedebergs Arch Pharmacol; 2021 Sep; 394(9):1917-1928. PubMed ID: 34061228
[TBL] [Abstract][Full Text] [Related]
19. Hyperoside attenuates neuroinflammation, cognitive impairment and oxidative stress via suppressing TNF-α/NF-κB/caspase-3 signaling in type 2 diabetes rats.
Chen X; Famurewa AC; Tang J; Olatunde OO; Olatunji OJ
Nutr Neurosci; 2022 Aug; 25(8):1774-1784. PubMed ID: 33722183
[TBL] [Abstract][Full Text] [Related]
20. α-Bisabolol Attenuates Doxorubicin Induced Renal Toxicity by Modulating NF-κB/MAPK Signaling and Caspase-Dependent Apoptosis in Rats.
Arunachalam S; Nagoor Meeran MF; Azimullah S; Jha NK; Saraswathiamma D; Subramanya S; Albawardi A; Ojha S
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
